Introduction: Hyperbaric Oxygen Therapy (HBOT) is FDA-approved for late radiation tissue injuries, which increases oxygen delivery to damaged tissue 10-14 times the standard amount.
Methods: A review were acquired by searching in databases of PubMed, Mdpi, Sciencedirect and ResearchGate.
Results: The HBOT sessions showed reducing pain, fibrosis and other radiation-related complications such as RHC in randomized clinical trials. It also complete remission of hematuria and improve disorders such as hypoxia and ischemia.
Conclusion: This review provides insights into the potential of HBOT. Despite challenges like cost and availability, HBOT is a valuable, low-risk effective treatment for suitable patients.